Add time:08/18/2019         Source:sciencedirect.com

The aim of the present study was to compare, in chloral-hydrate anaesthetized rats, the α2-adrenergic properties of the selective 5-HT1A receptor agonist, ALNESPIRONE (cas 138277-78-8) (S-20499), with those of buspirone, a 5-HT1A receptor agonist exhibiting potent α2-adrenoceptor antagonist properties via its principal metabolite, 1-(2-pyrimidinyl)-piperazine. Both locus coeruleus spontaneous firing activity and noradrenaline release in the medial prefrontal cortex were potently inhibited by the α2-adrenoceptor agonist clonidine, at a dose of 40 μg/kg (i.p.). Such an inhibition was neither prevented nor reversed by alnespirone (10 mg/kg, i.p.), while buspirone, at the same dose, potently antagonized the locus coeruleus inhibitory effects of clonidine. These data demonstrate that, in contrast with some aryl-piperazine compounds (such as buspirone), alnespirone, either on its own or via a possible metabolite such as buspirone, is devoid in vivo of significant α2-adrenoceptor antagonist properties.

We also recommend Trading Suppliers and Manufacturers of ALNESPIRONE (cas 138277-78-8). Pls Click Website Link as below: cas 138277-78-8 suppliers